EDWARDS DESIGN & FABRICATION M O D U L A R M I L I T A R Y B A L L I S T I C S H E L T E R S • Blast and bullet resistance to protect soldiers and military assets in mortar pits, shelters, and guard towers • Lightweight for portability and quick deployment without heavy equipment • Specific colors required to provide visual cover in the field • Provided UL 752 Level 3 ballistic resistance, additional protection by layering panels • Reduced weight by 75% compared to steel, improved portability over concrete or sandbags • Enabled easy installation with common carpentry tools • Customized color formulations to meet needed camouflage without painting GlasArmor™ Ballistic Resistant Composite Panels KEY REQUIREMENTS WHY AVIENT?

WALL PARTITION MANUFACTURER F O O D P R O C E S S I N G E N V I R O N M E N T S • Decrease growth of microbes on plastic surfaces that come in contact with food products • Compatibility with sheet extrusion processing • Maintain all other functional attributes inherent to product, such as ROHS, flame retardant standards, and specific brand color • Seamlessly incorporated multifunctional additives for optimal performance in reducing microbe growth • Developed custom formulation for complex processing configurations in sheet extrusion technology • Provided expertise in antimicrobial performance, chemical resistance, flame retardance, and regulatory product stewardship Cesa™ WithStand™ Antimicrobial Additives and Smartbatch™ Combination Colorants and Additives KEY REQUIREMENTS WHY AVIENT?

OnFlex LO - HVAC Flap - Spanish PROVEEDOR TIER 2 R E J I L L A P A R A S I S T E M A S D E V E N T I L A C I Ó N Y C A L E F A C C I Ó N • Eliminar el post-calentamiento de las piezas a fin de lograr el nivel de olor necesario (≤3.0 VDA 270) • Tener la menor emisión de compuestos orgánicos volátiles (VOC/FOG) (VDA 278), con el mismo compresión set del material anterior • Menos pasos de procesamiento y menores costos de energía para el moldeador • Se lograron los niveles VOC/FOG requeridos y se cumplió el desempeño con el estándar de compresión set OnFlex™ LO REQUERIMIENTOS CLAVE ¿POR QUÉ AVIENT?

MEDICAL DEVICE MANUFACTURER S T E T H O S C O P E S • Provide a silicone paste colorant dispersion for liquid silicone rubber (LSR) to use in stethoscope ear tips • Create a custom-colored vinyl plastisol formulation for stethoscope tubing • Harmonize color across materials to meet specific process and performance requirements • Deliver effective communication and cross-functional collaboration • Offered dependable silicone paste colorants that allowed for comfort and easy sterilization • Provided a colored vinyl plastisol to reduce tackiness and support product longevity • Collaborated internally to align all materials and provide color consistency across components • Supported fast color changes and met quality specifications through constant communication and technical expertise Silcopas Silicone Paste Colorants and CORE Vinyl Plastisols for Healthcare KEY REQUIREMENTS WHY AVIENT?

: 14/12/1990 Company Type : PRIVATE COMPANY LIMITED BY SHARES Status : Live Company Status Date : 14/12/1990 Principal Activities Activities (I) WHOLESALE TRADE OF A VARIETY OF GOODS WITHOUT A DOMINANT PRODUCT (46900) : IMPORT/EXPORT AND SALES OF POLYMERS Description : Activities (II) : Description Capital CurrencyIssued Share Capital Share TypeNumber of Shares * (AMOUNT) 694600 SINGAPORE, DOLLARS ORDINARY694600 7200000 UNITED STATES OF AMERICA, DOLLARS ORDINARY7200000 * Number of Shares includes number of Treasury Shares CurrencyPaid-Up Capital Share TypeNumber of Shares (AMOUNT) 694600 SINGAPORE, DOLLARS ORDINARY 7200000 UNITED STATES OF AMERICA, DOLLARS ORDINARY Page 1 of 4 Number Of Shares Currency COMPANY HAS THE FOLLOWING ORDINARY SHARES HELD AS TREASURY SHARES Registered Office Address 3 INTERNATIONAL BUSINESS PARK #04-14/15 NORDIC EUROPEAN CENTRE SINGAPORE (609927) Date of Address 16/08/2020: Date of Last AGM : 29/08/2020 Date of Last AR : 26/10/2020 FYE As At Date of Last AR : 31/12/2019 Audit Firms NAME ERNST & YOUNG LLP Amount Secured Chargee(s) Charges CurrencyCharge No. Date Registered ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Date of Appointment XU TAO EB6238077 CHINESE 30/06/2021ACRA DirectorROOM 102, BUILDING 20, SUB LANE 7, LANE 888, LUOJIN ROAD SHANGHAI, 201104, CHINA CHAN BAI RONG S8534833G SINGAPORE CITIZEN 30/06/2021ACRA Director10A BENDEMEER ROAD #26-103 BENDEMEER LIGHT SINGAPORE (331010) LEE SAY ENG A52290094 MALAYSIAN 30/06/2021ACRA Page 2 of 4 ID Officers/Authorised Representative(s) Position Held Nationality/CitizenshipName Date of Appointment Director168 JINAN ROAD, BUILDING 10, ROOM 802, SHANGHAI CHINA 200021 CHAN LAI YIN S7480587F MALAYSIAN 28/06/2010ACRA Secretary26 SIMEI STREET 1 #11-08 MELVILLE PARK SINGAPORE (529947) LEE WEI HSIUNG S7927166G SINGAPORE CITIZEN 01/12/2009ACRA Secretary633 JURONG WEST STREET 65 #10-310 SINGAPORE (640633) Shareholder(s) Name ID Nationality/Citizenship Place of incorporation/ Origin/Registration Address Changed AVIENT CORPORATION T05UF0103G UNITED STATES OF AMERICA ACRA1 33587 WALKER ROAD, AVON LAKE, OHIO 44012, UNITED STATES OF AMERICA Ordinary(Number) Currency 694600 SINGAPORE, DOLLARS Ordinary(Number) Currency 7200000 UNITED STATES OF AMERICA, DOLLARS Page 3 of 4 Abbreviation UL - Local Entity not registered with ACRA UF - Foreign Entity not registered with ACRA AR - Annual Return AGM - Annual General Meeting FS - Financial Statements OSCARS - One Stop Change of Address Reporting Service by Immigration & Checkpoint Authority.

AAE FL PINK UV U-BLUE PE UV CC RED CO-PET

S/ STEPHEN D. s/ Stephen D. s/ Bradley C.

  • A reconciliation of each non‐GAAP financial measure with the most directly  comparable GAAP financial measure is attached to this presentation which is co pa ab e G a c a easu e s attac ed to t s p ese tat o c s posted on our website at www.polyone.com.  Page 3 Strategy and Execution Drive Results 90% $22 $24 PolyOne Stock Price 50% $18 $20 $22 S&P 500 (relative performance) 30% $12 $14 $16 S&P 500 (relative performance) ‐10% 10% $6 $8 $10 50% ‐30% $0 $2 $4 $ | ‐50%$0 2006 2007 2008 2009 2010 2011 2012 2013 Page 4 Four Pillar Strategy The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized  Polymer Materials, Services & Solutions Page 5 Spartech – Compelling Strategic Rationale • Spartech expands PolyOne’s specialty portfolio with adjacent  technologies in attractive end markets  Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only  6% of Spartech’s revenues are outside of North America • PolyOne has a proven management team with a track record of  transformational success • Preliminary synergy estimated at $65 million run rate by end of  3year 3  Significant opportunity to expand profitability by leveraging  PolyOne’s four pillar strategy • Substantial potential share price appreciation for all  shareholders f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once  synergies realized Page 6 Mix Shift Highlights Specialty Transformation  Old  PolyOne Transformation 100% 2015 Target 80% In co m e*   65 – 75%40% 60% f O pe ra tin g  34% 43% 45% 65  75% 20%  o f 2%0% 2005 2008 2010 2012 2015 Specialty OI $5M   $46M                        $87M                       $114M                     Target *Operating Income excludes corporate charges and special items JV's PP&S Distribution Specialty Page 7 Proof of Performance 2007 2012 2015 “Where we were” “Where we are” “Where we Where we were Where we are expect to be" 1)  Operating Income % Specialty 3.2% 9.1% 12 – 16% PP&S 6.1% 9.0% 9 – 12% Distribution 3.0% 6.4% 6 – 7.5% 2)  Specialty Platform sss% of Operating Income 20% 45% 65 – 75% 3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15% 4)  Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit  Expansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period **4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS Page 8 Proof of Performance Spartech Opportunity Intermediate  PolyOne Spartech Opportunity 2006 2012 Today Goal “Where we were” “Where we are” “Where  Spartech is”* “Where we can go”were are Spartech is can go Specialty Operating Margin 1.5% 9.1% 2.2% 8.0% – 10.0%  Margin Page 9 *Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012 PolyOne 14% Latin America 3% Distribution 2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion* United States 14% 5% PP&S 20%Specialty 57% Building & HealthCare 1.02 1.20 $1.20 $1.40 ha re End Markets* EPS Growth Construction 14% 17% Industrial 9% 0.27 0 21 0.79 $0.40 $0.60 $0.80 $1.00 Ad ju st ed  E ar ni ng s P er  S Electrical & 0.12 0.21 0.13 $0.00 $0.20 2006 2007 2008 2009 2010 2011 2012 Page 10 * Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms Specialty U it d 2012 Revenues: $2.4 Billion* Solutions United States 59% 9% Latin America Building & C t ti HealthCare   o f S al es 12-16% End Markets* Expanding Profits Construction Electrical & Industrial 15% 1.5% 3.2% 4.3% 5.3% 8.4% 9.1% O pe ra tin g  In co m e  Page 11 2006 2007 2008 2009 2010 2011 2012 2015 O Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms Designed Structures and Solutions United States 2012 Revenues: $0.85 Billion* Solutions 84% Latin America 4% Building & Construction Sign & Advertising 3% Recreation & Leisure Pool & Spa 1% Distribution & Thermoform 2% Operating Income % of Sales 2012 Revenue by Industry Segment* Expanding Profits** Electrical & Electronics 23%Industrial 3% 2.2% 8 ‐ 10% 1% HealthCare 2012 2015 Target  Page 12 *Pro Forma includes FY2012 results for Spartech (11/03/12 YE) **Pro Forma results include Spartech corporate allocations for FY12 Positioned for Earnings Growth 2015 Target Rev: $5B Adj.  EPS: $2.50 Assumptions • High single digit organic  revenue CAGR • Operating margins in mid range  of 2015 targets • No global recession• No global recession • No investment in incremental  PP&S capacity • Completion of 2‐3 midsize  accretive acquisitions • No divestitures  • Housing starts at 85% of 50 year  norm by 2015 R i f t bl b l 3X N t 2012 $ • Remain comfortably below 3X Net  Debt / EBITDA Page 13 Rev: $3.0B Adj. 

DUAL-BAND ANTENNA MANUFACTURER P O S I T I O N I N G S Y S T E M • Ceramic replacement • Miniaturization • Moldable • Formulated materials for specific Dk/Df values • Delivered lower signal loss versus ceramic • Enhanced mechanical properties and eliminated secondary processing • Provided stable dielectric performance during injection molding process Edgetek™ Dielectric Constant (Dk) Formulations KEY REQUIREMENTS WHY AVIENT?

Versaflex HC - Syringe Plunger - English SYRINGE MANUFACTURER D I S P O S A B L E S Y R I N G E P L U N G E R • USP VI and ISO 10993-4,5 compliant • Sterilize by gamma & EtO • Long-term sealing performance • Low coefficient of friction (COF) • Consistent performance across barrel sizes • Provided a formulated solution that met rigorous medical application requirements • Improved global supply continuity • Increased process efficiency by replacing previous thermoset material with TPE Versaflex™ HC 2110-57B KEY REQUIREMENTS WHY AVIENT?